| Structure | Chemical Name | CAS | MF |
|
Dabelotine
|
118976-38-8
|
C15H22N2O2
|
|
9-hydroxylamine-1,2,3,4-tetrahydroacridine
|
118976-89-9
|
C13H14N2O
|
|
4-(4-Methoxybenzoyl)-2-thiophenesulfonamide
|
118976-97-9
|
C12H11NO4S2
|
|
PER-O-ACETYL-ALPHA-THIOPHENYL-N-ACETYLNEURAMINIC METHYL ESTER
|
118977-26-7
|
C26H33NO12S
|
|
angiotensin II amide (1-7), Sar(1)-
|
118977-33-6
|
|
|
(2-Hydroxyethyl)trimethylammonium dimethylphosphate
|
118978-98-6
|
C5H14NO.C2H6O4P
|
|
1-(3-AMINO-PROPYL)-HOMOPIPERIDINE DIHYDROCHLORIDE
|
118979-65-0
|
C9H21ClN2
|
|
viscumneoside VI
|
118985-26-5
|
C24H26O12
|
|
viscumneoside III
|
118985-27-6
|
C27H32O15
|
|
vertaline B
|
118985-28-7
|
C27H45NO3
|
|
2-Azetidinone, 3-acetyl-1,3-dimethyl-4-methylene- (9CI)
|
118987-40-9
|
C8H11NO2
|
|
2-Azetidinone, 3-acetyl-4-ethylidene-1,3-dimethyl-, (E)- (9CI)
|
118987-41-0
|
C9H13NO2
|
|
2-Azetidinone, 3-acetyl-4-ethylidene-1,3-dimethyl-, (Z)- (9CI)
|
118987-42-1
|
C9H13NO2
|
|
ethyl 2-(2-(2-(2-hydroxyethoxy)ethoxy)ethoxy)acetate
|
118988-04-8
|
C10H20O6
|
|
lanreotide
|
118992-92-0
|
C54H69N11O10S2
|
|
1-phenyl-3-phenylamino-4-(4-toluenesulfinyl)-1,5-hexadiene
|
118993-44-5
|
C25H25NOS
|
|
4-(4-Hydroxybenzoyl)-2-thiophenesulfonamide
|
118993-57-0
|
C11H9NO4S2
|
|
4-(4-Methoxybenzoyl)-2-furansulfonamide
|
118993-61-6
|
C12H11NO5S
|
|
3-(4-METHYLBENZOYL)THIOPHENE
|
118993-65-0
|
C12H10OS
|
|
3-(3-METHYLBENZOYL)THIOPHENE
|
118993-70-7
|
C12H10OS
|
|
2-Pentanone, 3,4-dihydroxy-, [S-(R*,S*)]- (9CI)
|
118994-78-8
|
C5H10O3
|
|
Oxazole-4-carbaldehyde
|
118994-84-6
|
C4H3NO2
|
|
5-OXAZOLECARBOXALDEHYDE
|
118994-86-8
|
C4H3NO2
|
|
ETHYL OXAZOLE-5-CARBOXYLATE
|
118994-89-1
|
C6H7NO3
|
|
OXAZOLE-5-CARBOXYLIC ACID
|
118994-90-4
|
C4H3NO3
|
|
D-erythro-2-Pentulose, 1,5-dideoxy- (9CI)
|
118994-93-7
|
C5H10O3
|
|
(2S,4R)-3-Benzoyl-4-methyl-2-phenyl-5-oxazolidinone
|
118995-17-8
|
C17H15NO3
|
|
(2S,4R)-3-BENZOYL-4-ETHYL-4-METHYL-2-PHENYL-OXAZOLIDIN-5-ONE
|
118995-18-9
|
C19H19NO3
|
|
1,3,3-TRIMETHYL-2-[(E)-3-(1,3,3-TRIMETHYL-1,3-DIHYDRO-2H-INDOL-2-YLIDENE)-1-PROPENYL]-3H-INDOLIUM TETRAPHENYLBORATE
|
118996-03-5
|
C49H49BN2
|
|
4,4',4''-nitrilotribenzoic acid
|
118996-38-6
|
C21H15NO6
|
|
4-CHLORO-6-(METHYLSULFANYL)-2-PHENYL-5-PYRIMIDINECARBONITRILE
|
118996-61-5
|
C12H8ClN3S
|
|
PEPTIDE YY, HUMAN
|
118997-30-1
|
C194H295N55O57
|
|
|
Lipidin-2
|
118997-96-9
|
|
|
W 77
|
118998-51-9
|
C31H40N4O6S
|
|
Bicyclo[2.2.1]hept-5-en-2-one, 7-(1-methylethylidene)-, oxime (9CI)
|
118999-99-8
|
C10H13NO
|
|
TRIS(4-FORMYLPHENYL)AMINE
|
119001-43-3
|
C21H15NO3
|
|
3-Amino-4,5,6-trimethylthieno[2,3-b]pyridine-2-carboxamide
|
119003-37-1
|
C11H13N3OS
|
|
2-AMINO-6-PHENYL-4,5,6,7-TETRAHYDRO-BENZO[B]THIOPHENE-3-CARBOXYLIC ACID METHYL ESTER
|
119004-72-7
|
C16H17NO2S
|
|
B-D-Glucopyranose,1,6-anhydro-2-azido-2-deoxy-,3,4-diacetate
|
119005-80-0
|
C10H13N3O6
|
|
4-(4-DIETHYLAMINOPHENYLIMINO)-1-OXO-1,4-DIHYDRONAPHTHALENE-2-CARBONITRILE
|
119006-66-5
|
C21H19N3O
|
|
Flutrimazole
|
119006-77-8
|
C22H16F2N2
|
|
5,6-DIHYDRO PGE3
|
119008-22-9
|
C20H32O5
|
|
(2R,5R)-N-Benzyl-2,5-dimethylpyrrolidine
|
119008-53-6
|
C13H19N
|
|
benidipine
|
119009-44-8
|
C28H31N3O6
|
|
benidipine
|
119009-45-9
|
C28H31N3O6
|
|
2-(TRIFLUOROMETHYL)-DL-PHENYLALANINE
|
119009-47-1
|
C10H10F3NO2
|
|
HYDROTRIS(3-ISOPROPYL-4-BROMOPYRAZOL-1-YL)BORATE POTASSIUM SALT
|
119009-98-2
|
C18H25BBr3KN6O3
|
|
7-Chloro-2-(Methylsulfanyl)-[1,3]thiazolo[4,5-d]pyriMidine
|
119011-56-2
|
C6H4ClN3S2
|
|
|
1,2,3-Propanetriol, polymer with 1,3-diisocyanatomethylbenzene, methyloxirane and oxirane, nonylphenol-blocked
|
119012-30-5
|
|
|
|
1,2,3-Propanetriol, polymer with 2,4-diisocyanato-1-methylbenzene, methyloxirane and oxirane, nonylphenol-blocked
|
119012-31-6
|
|
|
|
1,2,3-Propanetriol, polymer with 2,4-diisocyanato-1-methylbenzene, methyloxirane, oxirane and 1,2-propanediol, nonylphenol-blocked
|
119012-32-7
|
|
|
|
1,2,3-Propanetriol, polymer with 1,3-diisocyanatomethylbenzene, methyloxirane, oxirane and 1,3-propanediol, nonylphenol-blocked
|
119012-33-8
|
|
|
2-Propenoic acid, 2-methyl-, butyl ester, polymer with 2-(dimethylamino)ethyl 2-methyl-2-propenoate, ethenylbenzene, 2-ethylhexyl 2-propenoate and methyl 2-methyl-2-propenoate
|
119012-34-9
|
C40H65NO8
|
|
2,4-Cyclohexadien-1-ylamine,N,N-dimethyl-(6CI)
|
119015-41-7
|
C8H13N
|
|
Hexahydro-1H-isoindol-4(2H)-one
|
119015-44-0
|
C8H13NO
|
|
viscumneoside V
|
119016-92-1
|
C32H40O19
|
|
N-ETHYL-CARBAZOL-3-ALDEHYDE-N-METHYL-N-PHENYL-HYDRAZONE
|
119017-10-6
|
C22H21N3
|
|
LHRH, N-Ac(2)-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-5-(4-methoxyphenyl)-5-oxo-2-aminopentanoic acid(6)-Ala(10)-
|
119018-01-8
|
C73H96ClN17O15
|
|
N-acetyl-S-(1,1-dibromo-2,2-difluoroethyl)-1-cysteine
|
119018-03-0
|
C7H9Br2F2NO3S
|
|
N-acetyl-S-(1,1,2,2-tetrafluoroethyl)-1-cysteine
|
119018-04-1
|
C7H9F4NO3S
|
|
4-(4-Methylbenzoyl)-2-thiophenesulfonamide
|
119018-06-3
|
C12H11NO3S2
|
|
4(1H)-Pteridinone, 5,8-dihydro- (9CI)
|
119018-17-6
|
C6H6N4O
|
|
(3E)-4-(1,2-Dimethyl-6-([2-(trimethylsilyl)ethoxy]methoxy)cyclohexyl)- 3-buten-2-one
|
119018-20-1
|
C18H34O3Si
|
|
4-[2-[(3-Ethyl-4-methyl-2-oxo-3-pyrrolin-1-yl)carboxamido]ethyl]benzenesulfonamide
|
119018-29-0
|
C16H21N3O4S
|
|
GLIMEPIRIDE RELATED COMPOUND C (20 MG) (GLIMEPIRIDE URETHANE)
|
119018-30-3
|
C18H23N3O6S
|
|
H-SER-ALA-LEU-ARG-HIS-TYR-ILE-ASN-LEU-ILE-THR-ARG-GLN-ARG-TYR-NH2
|
119019-65-7
|
C85H139N29O21
|
|
benzyl 2-(aminomethyl)pyrrolidine-1-carboxylate hydrochloride
|
119020-00-7
|
|
|
(S)-1-N-Boc-2-(aminomethyl)pyrrolidine
|
119020-01-8
|
C10H20N2O2
|
|
(S)-2-(Aminomethyl)-1-Cbz-pyrrolidine
|
119020-03-0
|
C13H18N2O2
|
|
(2R)-PYRROLIDINEMETHANAMINE DIHYDROCHLORIDE
|
119020-04-1
|
C5H12N2.2ClH
|
|
1-N-CBZ-2-CYANOPYRROLIDINE
|
119020-06-3
|
C13H14N2O2
|
|
6,6'-bi(7-allyl-3-oxo-4-estren-17-yl acetate)
|
119020-36-9
|
C46H62O6
|
|
1-METHYL-5-(TRIFLUOROMETHYL)-1H-PYRAZOL-3-OL
|
119022-51-4
|
C5H5F3N2O
|
|
Benzamide, 2-amino-4-fluoro- (9CI)
|
119023-25-5
|
C7H7FN2O
|
|
2-(3,5-DICHLOROPHENOXY)ETHANETHIOAMIDE
|
119024-27-0
|
C8H7Cl2NOS
|
|
1-Heptanol, 5-(aminomethyl)-6-methyl-
|
119026-20-9
|
C9H21NO
|
|
Ethanone, 1-(2-fluoro-1-hydroxycyclohexyl)-, trans- (9CI)
|
119030-21-6
|
C8H13FO2
|
|
Ethanone, 1-(1-fluoro-2-hydroxycyclohexyl)-, trans- (9CI)
|
119030-22-7
|
C8H13FO2
|
|
3-OXO-3-(2-PHENOXYPHENYL)PROPIONIC ACID ETHYL ESTER
|
119031-24-2
|
C17H16O4
|
|
2,2',4,4',5-pentachlorodiphenyl ether
|
119036-18-9
|
|
|
Hexakis-(2,6-di-O-pentyl-3-O-acetyl)-alpha-Cyclodextrin
|
119037-99-9
|
C108H192O36
|
|
D-AMPHETAMINE-D3 SULFATE SALT
|
119039-59-7
|
C18H22D6N2O4S
|
|
5A-ANDROSTANE-3A,17B-DIOL 17-SULFATETRIE THYLAMMONI
|
119039-60-0
|
C19H31O5S.Na
|
|
5-ANDROSTENE-3B,17B-DIOL 3-SULFATETRIETH YLAMMONIUM
|
119039-62-2
|
C25H46NO5S+
|
|
poly(L-glutamic acid-L-tyrosine) sodium salt
|
119039-70-2
|
C14H22N3NaO6
|
|
POLYDEOXYGUANYLIC-POLYDEOXYCYTIDYLIC ACID SODIUM SALT
|
119039-74-6
|
C19H28N8O14P2
|
|
POLY(ORN, LEU) HYDROBROMIDE
|
119039-76-8
|
C11H26BrN3O4
|
|
POLY(D-GLU, D-LYS) HYDROBROMIDE
|
119039-80-4
|
C11H25BrN4O5
|
|
POLY(ORN, SER) HYDROBROMIDE
|
119039-84-8
|
C8H20BrN3O5
|
|
POLY(LYS, TYR) HYDROBROMIDE
|
119039-85-9
|
C17H27BrN4O4
|
|
POLY(GLU, ALA) SODIUM SALT
|
119039-86-0
|
C8H18N3NaO5
|
|
POLYMALEIMIDE SODIUM MOL. WT.*5,000-10,000
|
119039-87-1
|
C4H3NO2
|
|
POLY(GLU, LYS) HYDROBROMIDE
|
119039-90-6
|
C11H25BrN4O5
|
|
POLY(ORN, TRP) HYDROBROMIDE
|
119039-91-7
|
C16H25BrN4O4
|
|
POLY(ARG, TRP) HYDROCHLORIDE
|
119039-92-8
|
C17H27ClN6O4
|
|
|
PENTACARBOXYLPORPHYRIN I*PERMETHYL ESTER
|
119039-95-1
|
C42H48N4O10
|
|
prednisone sodium succinate
|
119042-10-3
|
C25H29O8*Na
|
|
4-{2-{[(3-Ethyl-2,5-dihydro-4-methyl-2-oxo-1H-pyrrol-1-yl)-carbonyl]-amino}-ethyl}-benzenesulfonyl chloride
|
119043-16-2
|
C16H19ClN2O4S
|
|
2-CHLORO-4-NITROPHENYL-ALPHA-D-GLUCOPYRANOSIDE
|
119047-14-2
|
C12H14ClNO8
|
|
ARG-PHE-NH2
|
119051-99-9
|
C15H24N6O2
|